Home » Topics » Immuno-oncology, BioWorld Science

Immuno-oncology, BioWorld Science
RSS

CPMP hands down positive opinion for survival claim for MabCampath

June 30, 2003

Preliminary findings for Ceplene in stage IV malignant melanoma

June 26, 2003

Phase III Theratope vaccine trial fails to meet primary endpoints

June 19, 2003

Interferon alfa variants with enhanced immunomodulatory and antitumor activity

June 17, 2003

Dendreon's phase III trial will serve as basis for Provenge approval

June 17, 2003

Preliminary evidence of immune response reported in Norelin trial

June 16, 2003

3M submits sNDA for Aldara in superficial basal cell carcinoma

June 13, 2003

Preclinical efficacy of a humanized anti-CD20 monoclonal antibody against NHL

June 13, 2003

MedImmune and Micromet to codevelop MT-103

June 12, 2003

Positive interim data from phase II trial of Allovectin-7 reported at ASCO

June 12, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...